DFMO, a forgotten sleeping sickness drug, shows early promise against ultra-rare genetic disorder BABS by targeting the root genetic cause, but faces regulatory and supply hurdles.
Scientists captured the first 3D view of killer T cells forming a precise contact zone to destroy cancer cells, revealing molecular choreography that could transform immunotherapy.
Scientists discovered rare flavoalkaloids and dozens of unknown compounds in cannabis leaves, revealing hidden medical potential and significant chemical variation between strains.
A new DNA-based therapy targets PCSK9 to lower LDL cholesterol by nearly 50%, offering an effective alternative to statins, especially for those with genetic high cholesterol or statin intolerance.
Hospital AI system rebuilt with multi-LLM fallback achieves 100% uptime, eliminating single points of failure that previously caused morning report outages.
BioticsAI CEO Robhy Bustami reveals strategy for FDA approval, fundraising, and team motivation in regulated healthcare AI, offering a blueprint for startups.
Step-by-step guide to access DFMO treatment for Bachmann-Bupp syndrome: from diagnosis confirmation to navigating clinical trials and regulatory hurdles.
Step-by-step guide explaining how killer T cells precisely recognize, engage, and destroy cancer cells using the immunological synapse and cytotoxic granules, based on breakthrough 3D imaging.
Learn how to harvest and preserve cannabis leaves to retain rare flavoalkaloids with medicinal potential, ensuring you don't waste these valuable plant parts.
Step-by-step explanation of a new DNA-based therapy that lowers LDL cholesterol by 50% by targeting PCSK9 protein, providing a statin-free alternative.
BioticsAI CEO Robhy Bustami shares insights on FDA approval, fundraising challenges, and maintaining team morale in heavily regulated healthcare sector, with strategic advice for medtech entrepreneurs.
A step-by-step guide on safely using vitamin D supplements to potentially boost breast cancer chemotherapy success, including consultation, testing, dosing, and monitoring.
Learn how MIT scientists transformed chaotic laser light into a focused pencil beam for 3D brain imaging, enabling 25x faster blood-brain barrier visualization.
Rivian posts Q1 revenue jump, delivers 10,365 vehicles (+20% YoY) as R2 production starts, reaffirms 62-67k full-year forecast. Path to profitability seen.
Rivian Q1 2026 earnings: revenue up, R2 production begins, sales jump 20%, production up 30%. Full-year forecast holds at 62-67k vehicles.
The 2026 Match set records but sparked false claims about IMGs taking spots. Data shows USMGs dominate, IMGs fill critical gaps, and collaboration beats restriction.
Eight key takeaways from the RFK Jr. congressional hearings, including NIH funding debates, bipartisan pushback on cuts, and voter demand for vaccine access.
A new tool predicts risk of 18 obesity complications using BMI, family history, diet, illness, and socioeconomic factors, aiming to guide GLP-1 drug prescriptions.
Akeso's ivonescimab earns ASCO plenary spot for lung cancer survival data, sparking speculation. This listicle covers 10 key insights including drug mechanism, trial design, regulatory impact, and market implications.
10 critical facts about wildfire smog's rising harm: health risks, vulnerable groups, climate links, long-distance spread, and actionable steps to stay safe.